About Pricing FAQs Providers Trials Blog

Back to your record

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Breast Cancer Clinical Trials in Minneapolis | 338 Studies

Clinical Trials Breast CancerMinneapolis

Breast Cancer Clinical Trials in Minneapolis

Find 338 clinical trials for breast cancer near Minneapolis, Minnesota. Connect with research centers in your area.

All Breast Cancer trials nationwide All trials in Minneapolis

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4Not applicable

Who can join

Healthy volunteers too

Showing 261-280 of 338 trials

CompletedTriptorelin With Either Exemestane or Tamoxifen in Treating Premenopausal Women With Hormone-Responsive Breast CancerRATIONALE: Estrogen can stimulate the growth of breast cancer cells.NCT00066703·Burbank, California and 227 others

Breast Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

CompletedIrinotecan and Docetaxel in Treating Patients With Refractory Metastatic Breast CancerRATIONALE: Drugs used in chemotherapy, such as irinotecan and docetaxel, work in different ways to stop tumor cells from dividing so they stop growing or die.NCT00079118·Scottsdale, Arizona and 161 others

CompletedStem Cell Injection in Cancer SurvivorsThe primary purpose of this study is to examine the safety and feasibility of delivering allogeneic human mesenchymal stem cells (allo-MSCs) by transendocardial injection to…NCT02509156·Stanford, California and 6 others

CompletedNutrition Intervention in Treating Women With Breast CancerRATIONALE: Dietary fat may be involved in the growth of cancer cells. Restricting dietary fat may help fight cancer.NCT00002564·Birmingham, Alabama and 36 others

CompletedPharmacokinetic Drug-drug Interaction Study of Dovitinib (TKI258) in Patients With Advanced Solid TumorsThis is a multi-center, open-label, phase I study to assess the effects of dovitinib (TKI258) on the pharmacokinetics of a cocktail of caffeine, diclofenac, omeprazole and…NCT01596647·Kansas City, Kansas and 4 others

CompletedPredictors of Lymphedema Following Breast Cancer SurgeryThe purpose of this study evaluate which factors play a role in lymphedema development among women who have had axillary surgery for breast cancer.NCT00202046·Minneapolis, Minnesota and 2 others

CompletedAdj TC + Herceptin Early Stage Breast CancerThe purpose of this research study is to find out what effects (good and bad) docetaxel/cyclophosphamide (brand names: Taxotere and Cytoxan, or TC) plus trastuzumab (brand name…NCT00493649·Birmingham, Alabama and 68 others

Active not recruitingTesting Longer Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With Cancer That Has Spread to the BrainThis phase III trial compares the effectiveness of fractionated stereotactic radiosurgery (FSRS) to usual care stereotactic radiosurgery (SRS) in treating patients with cancer…NCT06500455·Tucson, Arizona and 269 others

CompletedDWI in Assessing Treatment Response in Patients With Breast Cancer Receiving Neoadjuvant ChemotherapyRATIONALE: Imaging procedures, such as diffusion-weighted magnetic resonance imaging (DWI) and dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI), may help in…NCT01564368·Birmingham, Alabama and 6 others

CompletedCharacterization of Circulating Tumor Cells (CTC) From Patients With Metastatic Breast Cancer Using the CTC-Endocrine Therapy IndexUtilizing CellSearch® technology, the ability to both enumerate and reliably and reproducibly characterize circulating tumor cells (CTC) for tumor markers that predict endocrine…NCT01701050·Phoenix, Arizona and 19 others

CompletedBexarotene in Treating Patients With Metastatic Breast CancerRATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die.NCT00003752·Birmingham, Alabama and 29 others

RecruitingCollecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer DetectionThis study collects blood and tissue samples from patients with cancer and without cancer to evaluate tests for early cancer detection.NCT05334069·Anchorage, Alaska and 750 others

SuspendedTesting Low Dose Tamoxifen for Invasive Breast Cancer, LoTam TrialThis phase III trial compares the effect of low dose tamoxifen to usual hormonal therapy, including aromatase inhibitors, in treating post-menopausal women with hormone positive…NCT06671912·Anchorage, Alaska and 731 others

CompletedThe XENERA™ 1 Study Tests Xentuzumab in Combination With Everolimus and Exemestane in Women With Hormone Receptor Positive and HER2-negative Breast Cancer That Has SpreadThe main objective of the trial is to assess the efficacy of xentuzumab in combination with everolimus and exemestane over everolimus and exemestane in patients with HR+/ HER2-…NCT03659136·Chandler, Arizona and 53 others

CompletedALTTO (Adjuvant Lapatinib And/Or Trastuzumab Treatment Optimisation) Study; BIG 2-06/N063DThis was a four-arm (parallel group) randomized, open-label, multicenter Phase 3 study to investigate the use of a combination of Lapatinib and Trastuzumab, a sequence of…NCT00490139·Mobile, Alabama and 923 others

Active not recruitingPhII ICb With/Without Erbitux in MBC PtsThe purpose of this study is to determine the objective response rates produced by irinotecan and carboplatin therapy with or without Erbitux in patients with Metastatic Breast…NCT00248287·Birmingham, Alabama and 58 others

CompletedEnalapril Maleate and Doxorubicin Hydrochloride in Treating Women With Breast CancerRATIONALE: Drugs used in chemotherapy, such as doxorubicin hydrochloride, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them…NCT00895414·Edina, Minnesota and 1 other

Active not recruitingTesting Radiation and HER2-targeted Therapy Versus HER2-targeted Therapy Alone for Low-risk HER2-positive Breast CancerThis Phase III trial compares the recurrence-free interval (RFI) among patients with early-stage, low risk HER2+ breast cancer who undergo breast conserving surgery and receive…NCT05705401·Phoenix, Arizona and 417 others

CompletedTreatment With Pazopanib for Neoadjuvant Breast CancerThe purpose of this study is to determine whether the treatment of a doxorubicin in combination with cyclophosphamide followed by a combination of pazopanib in combination with…NCT00849472·Decatur, Alabama and 142 others

TerminatedA Phase II Study Comparing The Efficacy Of Venetoclax + Fulvestrant Vs. Fulvestrant In Women With Estrogen Receptor-Positive, Her2-Negative Locally Advanced Or Metastatic Breast Cancer Who Experienced Disease Recurrence Or Progression During Or After CDK4/6 Inhibitor TherapyThis is a Phase II, multicenter, open-label, randomized study to compare the efficacy of venetoclax in combination with fulvestrant compared with fulvestrant alone in women with…NCT03584009·Phoenix, Arizona and 39 others

PreviousPage 14 of 17Next

Other Conditions in Minneapolis

Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma